Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Genetic Disease | Family Medicine
Thalassemia Clinical Trials
A listing of Thalassemia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
California
Oakland California
A clinical trial to evaluate treatments using LentiGlobin® BB305 Drug Product for patients with Beta-thalassemia Major
Colorado
Children's Hospital Colorado
Aurora Colorado 80045
A Phase 2 clinical study for patients with Nonmalignant Neoplasm
District of Columbia
Massachusetts
Children's Hospital Boston
Boston Massachusetts 02115
A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia
Oregon
Oregon Health and Science University
Portland Oregon 97239
A Phase 2 clinical study for patients with Nonmalignant Neoplasm
Tennessee
Washington
Wisconsin
Children's Hospital of Wisconsin
Milwaukee Wisconsin 53201
A Phase 2 clinical study for patients with Nonmalignant Neoplasm
Australia
Novartis Investigative Site
Adelaide South Australia 5000
A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia
Novartis Investigative Site
Bedford Park South Australia 5042
A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia
Novartis Investigative Site
Camperdown New South Wales 2050
A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia
Novartis Investigative Site
East Bentleigh Victoria 3165
A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia
Novartis Investigative Site
Perth Western Australia 6000
A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia
View More »
Novartis Investigative Site
South Brisbane Queensland 4101
A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia
Novartis Investigative Site
St Leonards New South Wales 2065
A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia
Novartis Investigative Site
Woolloongabba Queensland 4102
A clinical research study of Single arm MRI test for the treatment of Thalassemia, Non-transfusion Dependent Thalassemia, Myelodysplastic Syndromes, Myelofibrosis, Other Anemia
Canada
Toronto Sick Kids Hospital
Toronto Ontario
A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia
China
Novartis Investigative Site
Nanning Guangxi 530021Updated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
France
Groupe Hospitalier Henri Mondor
Créteil
Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia
Hôpital Necker-Enfants Malades
Paris
Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia
Hôpital Necker Enfants Malades
Paris 75015
Patients are needed to participate in a clinical research study of Blood sample to evaluate Thalassemia, Sickle Cell Disease or Myelodysplasia
Greece
Novartis Investigative Site
Athens GR-115 27Updated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
Novartis Investigative Site
Athens GR 11527
Patients are needed to participate in a clinical research study of Deferasirox and Deferasirox + Deferoxamine to evaluate Transfusion-dependent β-thalassemia Patients or Cardiac Iron Overload
Novartis Investigative Site
Athens GR-115 27
Patients are needed to participate in a clinical research study of Deferasirox and Deferasirox + Deferoxamine to evaluate Transfusion-dependent β-thalassemia Patients or Cardiac Iron Overload
Novartis Investigative Site
Athens GR
Patients are needed to participate in a clinical research study of Deferasirox and Deferasirox + Deferoxamine to evaluate Transfusion-dependent β-thalassemia Patients or Cardiac Iron Overload
Novartis Investigative Site
Patras 26500
Patients are needed to participate in a clinical research study of Deferasirox and Deferasirox + Deferoxamine to evaluate Transfusion-dependent β-thalassemia Patients or Cardiac Iron Overload
View More »
George Papanicolaou Hospital
Thessaloniki
Patients are needed to participate in a clinical research study of Mozobil to evaluate Beta-Thalassemia
Italy
Ospedale Regionale Mecrocitemie
Cagliari 09121
A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia
Universita Degli Studi Di Cagliari
Cagliari 09121
Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia
Centro della Microcitemia e delle Anemie Congenite
Genoa
A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia
Ente Ospedaliero Ospedali Galliera
Genova 16128
Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia
Novartis Investigative Site
Milano MI 20122Updated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
View More »
Fondazione IRCCS Ospedale Maggiore
Milano 20122
Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia
Thalassemia Center San Luigi Hospital
Orbassano
A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia
University of Torino
Torino
Patients are needed to participate in a clinical research study of S-303 Treated Red Blood Cells (RBCs) and Conventional, untreated Red Blood Cells to evaluate Thalassemia Major
Acceleron Investigative Site
Turin
A clinical trial to evaluate treatments using ACE-536 for patients with Beta-thalassemia.
Lebanon
Novartis Investigative Site
Hazmiyeh Updated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
Thailand
Novartis Investigative Site
Bangkok 10700Updated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
Tunisia
Novartis Investigative Site
Tunis 1006Updated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
Turkey
Novartis Investigative Site
Adana 01330Updated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
Novartis Investigative Site
Istanbul 34093Updated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
Ege University Hospital
Izmir 35100
A Phase 2 clinical study for patients with Transfusional Iron Overload or Beta-Thalassemia
Novartis Investigative Site
Izmir 35040Updated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
United Kingdom
Novartis Investigative Site
London NW1 2PJUpdated
A Phase 4 clinical study for patients with Non-transfusion Dependent Thalassemia
UCL Cancer Institue
London WC1E6BT
Patients are needed to participate in a clinical research study evaluating SOTATERCEPT (ACE-011) for the treatment of Beta Thalassemia Major or Beta Thalassemia Intermedia